Cuba approved the second phase of clinical trials for its Soberana 02 COVID-19 vaccine candidate after registering preliminary positive results in the first phase of studies on humans, the Finlay Vaccine Institute (IFV) reported this Thursday. The IFV director general stated that this new phase of the study will involve a group of 100 volunteers … Continue reading Second phase of Cuban Soberana 02 vaccine candidate’s clinical trials approved